CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Revenue from collaboration and licensing	$ 3,696	$ 2,235
Operating expenses:
Research and development	(11,526)	(10,179)
General and administrative	(4,629)	(2,711)
Total operating expenses	(16,155)	(12,890)
Loss from operations	(12,459)	(10,655)
Other income (expense):
Grant income	1,472	1,192
Interest income	312	64
Interest expense	(227)	(213)
Other income and expenses, net	(24)	283
Total other income, net	1,533	1,326
Net loss before tax	(10,926)	(9,329)
Income tax expense	0	0
Net loss	(10,926)	(9,329)
Other comprehensive loss:
Foreign currency translation gain (loss), net of tax	(93)	(736)
Comprehensive loss	$ (11,019)	$ (10,065)
Net loss per share—basic and diluted	$ (0.43)	$ (9.27)
Weighted average common shares outstanding — basic and diluted	25,630,007	1,006,595